Your browser doesn't support javascript.
Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology.
Patti, Giuseppe; Lio, Veronica; Cavallari, Ilaria; Gragnano, Felice; Riva, Letizia; Calabrò, Paolo; Di Pasquale, Giuseppe; Pengo, Vittorio; Rubboli, Andrea.
  • Patti G; Department of Translational Medicine, "Maggiore della Carità" Hospital, University of Eastern Piedmont, Via Solaroli, 17, 28 100, Novara, Italy. giuseppe.patti@uniupo.it.
  • Lio V; Department of Translational Medicine, "Maggiore della Carità" Hospital, University of Eastern Piedmont, Via Solaroli, 17, 28 100, Novara, Italy.
  • Cavallari I; Campus Bio-Medico University of Rome, Rome, Italy.
  • Gragnano F; "Sant'Anna and San Sebastiano" Hospital of Caserta, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Riva L; "Maggiore" Hospital, Bologna, Italy.
  • Calabrò P; "Sant'Anna and San Sebastiano" Hospital of Caserta, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Di Pasquale G; "Maggiore" Hospital, Bologna, Italy.
  • Pengo V; Campus Biomedico "Pietro d'Abano", University of Padua, Padua, Italy.
  • Rubboli A; Fondazione Arianna" On Anticoagulation, Bologna, Italy.
Am J Cardiovasc Drugs ; 20(6): 559-570, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-910261
ABSTRACT
In patients with coronavirus disease 2019 (COVID-19), the prevalence of pre-existing cardiovascular diseases is elevated. Moreover, various features, also including pro-thrombotic status, further predispose these patients to increased risk of ischemic cardiovascular events. Thus, the identification of optimal antithrombotic strategies in terms of the risk-benefit ratio and outcome improvement in this setting is crucial. However, debated issues on antithrombotic therapies in patients with COVID-19 are multiple and relevant. In this article, we provide ten questions and answers on risk stratification and antiplatelet/anticoagulant treatments in patients at risk of/with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection based on the scientific evidence gathered during the pandemic.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / COVID-19 / Anticoagulants Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Am J Cardiovasc Drugs Journal subject: Vascular Diseases / Cardiology / Drug Therapy Year: 2020 Document Type: Article Affiliation country: S40256-020-00446-6

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / COVID-19 / Anticoagulants Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Am J Cardiovasc Drugs Journal subject: Vascular Diseases / Cardiology / Drug Therapy Year: 2020 Document Type: Article Affiliation country: S40256-020-00446-6